The monocyte-to-HDL-cholesterol ratio predicts new-onset atrial fibrillation in patients with acute STEMI
The present study revealed that increased MHR robust indicator for NOAF in STEMI patients and can be easily assessed in clinical practice. Incorporating MHR alongside established traditional risk factors may enhance the identification of patients at risk for AF in those with STEMI.
Authors
- Veysel Ozan Tanık (ORCID: https://orcid.org/0000-0002-7193-4324)
- Bülent Özlek (ORCID: https://orcid.org/0000-0001-5429-1323)
- Çağatay Tunca (ORCID: https://orcid.org/0000-0001-7111-8450)
- Ahmet Kıvrak (ORCID: https://orcid.org/0000-0001-5232-8436)
- Kamuran Kalkan (ORCID: https://orcid.org/0000-0002-1779-560X)
Institutions
- Hacettepe University (TR)
- Muğla University (TR)
Publication Details
- Journal
- Biomarkers in Medicine
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1080/17520363.2025.2459590
- Citations
- 3
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.16